Latest Strategy News

Elsight Limited has raised A$60 million through a strongly supported placement, marking a milestone with consecutive record revenues and cash flow breakeven. The company is poised to capitalize on surging defence budgets and expanding drone markets with a robust pipeline of opportunities.

Elsight Limited reports a record 340% revenue surge to US$4.8 million in the first half of 2025, backed by a robust US$11.45 million contract backlog and a strategic A$60 million capital raise to fuel expansion.

Encounter Resources has appointed key experts to accelerate development of its Aileron niobium-rare earth project, advancing metallurgical testing and market engagement.

Syrah Resources has resumed production and shipping from its Balama Graphite Operation in Mozambique, marking a significant step in restoring normal operations after earlier disruptions.

AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.

Legend Mining has officially surrendered its tenure over the Rockford Joint Venture tenements, marking the conclusion of its partnership with IGO Limited on this significant exploration project.

Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.

Paladin Energy reported a 33% jump in uranium production at its Langer Heinrich Mine, alongside a major permitting milestone for its Canadian Patterson Lake South Project. Leadership changes and strong safety performance round out a quarter of significant progress.

QPM Energy has successfully raised $7 million through an oversubscribed Share Purchase Plan, significantly exceeding its initial $2 million target to accelerate key gas power projects in Queensland.

Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.

Galileo Mining has kicked off a significant 5,000-metre aircore drilling campaign at its Norseman project, aiming to build on promising palladium and platinum results and grow its existing 1.27 million ounce palladium equivalent resource.

Westgold Resources capped FY25 with record quarterly gold production and a $132 million treasury boost, while announcing a maiden 2.3 million ounce resource at its Fletcher Zone.